MacGuire Cheswick & Tuttle Investment Counsel’s AbbVie ABBV Stock Holding History

MacGuire Cheswick & Tuttle Investment Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$575K	Hold	6,235	–	–	0.12%	68
2018 Q3	$590K	Hold	6,235	–	–	0.1%	73
2018 Q2	$578K	Sell	6,235 -25	-0.4%	-$2.44K	0.11%	72
2018 Q1	$593K	Buy	6,260 +200	+3%	+$22K	0.11%	73
2017 Q4	$586K	Buy	6,060 +360	+6%	+$33.9K	0.11%	73
2017 Q3	$507K	Hold	5,700	–	–	0.1%	73
2017 Q2	$413K	Hold	5,700	–	–	0.08%	73
2017 Q1	$371K	Hold	5,700	–	–	0.07%	75
2016 Q4	$357K	Hold	5,700	–	–	0.07%	73
2016 Q3	$359K	Hold	5,700	–	–	0.08%	70
2016 Q2	$353K	Hold	5,700	–	–	0.08%	69
2016 Q1	$326K	Sell	5,700 -900	-14%	-$50.2K	0.08%	70
2015 Q4	$391K	Hold	6,600	–	–	0.09%	71
2015 Q3	$359K	Hold	6,600	–	–	0.09%	76
2015 Q2	$443K	Hold	6,600	–	–	0.1%	75
2015 Q1	$386K	Hold	6,600	–	–	0.09%	79
2014 Q4	$432K	Buy	6,600 +900	+16%	+$56.7K	0.1%	80
2014 Q3	$329K	Hold	5,700	–	–	0.08%	81
2014 Q2	$322K	Hold	5,700	–	–	0.07%	77
2014 Q1	$293K	Sell	5,700 -17,050	-75%	-$862K	0.07%	80
2013 Q4	$1.2M	Sell	22,750 -77,773	-77%	-$3.82M	0.29%	61
2013 Q3	$4.5M	Buy	100,523 +700	+0.7%	+$31K	1.24%	32
2013 Q2	$4.13M	Buy	+99,823	New	+$4.37M	1.18%	32

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

MacGuire Cheswick & Tuttle Investment Counsel's ABBV Position: Q4 2018 in Review

MacGuire Cheswick & Tuttle Investment Counsel held its AbbVie (ABBV) position steady in Q4 2018 at 6,235 shares worth $575K. The position accounts for 0.12% of the portfolio, ranked #68.

MacGuire Cheswick & Tuttle Investment Counsel first reported a position in ABBV in Q2 2013 and has held it in 23 quarters since. The position peaked at $4.5M in Q3 2013. 2,063 funds tracked by Wall St. Rank hold ABBV as of Q4 2018.

MacGuire Cheswick & Tuttle Investment Counsel held 6,235 shares of AbbVie worth $575K as of Q4 2018.
MacGuire Cheswick & Tuttle Investment Counsel left its AbbVie share count unchanged in Q4 2018.
AbbVie made up 0.12% of MacGuire Cheswick & Tuttle Investment Counsel's portfolio in Q4 2018, its #68 holding.
MacGuire Cheswick & Tuttle Investment Counsel first reported a position in AbbVie in Q2 2013 and has held it in 23 quarters since.
MacGuire Cheswick & Tuttle Investment Counsel's AbbVie position peaked at $4.5M in Q3 2013.
2,063 funds tracked by Wall St. Rank held AbbVie as of Q4 2018.

Based on MacGuire Cheswick & Tuttle Investment Counsel's 13F filing for Q4 2018, filed 11 Feb 2019.